Neurofibromatosis type 1 associated low grade gliomas: A comparison with sporadic low grade gliomas

Jelte Helfferich, Ronald Nijmeijer, Oebele F. Brouwer, Maartje Boon, Annemarie Fock, Eelco W. Hoving, Lisethe Meijer, Wilfred F. A. den Dunnen, Eveline S. J. M. de Bont*

*Bijbehorende auteur voor dit werk

Onderzoeksoutputpeer review

72 Citaten (Scopus)
520 Downloads (Pure)


Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder, associated with a variable clinical phenotype including cafe-au-lait spots, intertriginous freckling, Lisch nodules, neurofibromas, optic pathway gliomas and distinctive bony lesions. NF1 is caused by a mutation in the NF1 gene, which codes for neurofibromin, a large protein involved in the MAPK- and the mTOR-pathway through RAS-RAF signalling. NF1 is a known tumour predisposition syndrome, associated with different tumours of the nervous system including low grade gliomas (LGGs) in the paediatric population. The focus of this review is on grade I pilocytic astrocytomas (PAs), the most commonly observed histologic subtype of low grade gliomas in NF1. Clinically, these PAs have a better prognosis and show different localisation patterns than their sporadic counterparts, which are most commonly associated with a KIAA1549:BRAF fusion.

In this review, possible mechanisms of tumourigenesis in LGGs with and without NF1 will be discussed, including the contribution of different signalling pathways and tumour microenvironment. Furthermore we will discuss how increased understanding of tumourigenesis may lead to new potential targets for treatment. (C) 2016 The Author(s). Published by Elsevier Ireland Ltd.

Originele taal-2English
Pagina's (van-tot)30-41
Aantal pagina's12
TijdschriftCritical Reviews in Oncology/Hematology
StatusPublished - aug.-2016

Citeer dit